The authors thank Angela Ehmer for coordinating the project and Dirk Schomburg (Institute for biometry and medical informatics) for statistical advice. We also thank the ARGOS-02 study sites for contacting the patients.
Supported by the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant Agreement No.675033 (EGRET plus) and No. 661883 (EGRET cofund).
Disclosure: J.J.O.N. van den Bosch, Implandata (E) Implandata is a beneficiary of the aforementioned EGRET plus international training program, which funds J.J.O.N. van den Bosch's PhD via Implandata; V. Pennisi, None; A. Invernizzi, None; K. Mansouri, Alcon (F), Allergan (F), Implandata (C, F), Santen (C); R.N. Weinreb, Aerie Pharmaceuticals (C), Allergan (C), Bausch & Lomb (C), Eyenovia (C), Implandata (C), Meditec-Zeiss (F), Optovue (F), Centervue (F), Heidelberg Engineering (F), Konan (F); H. Thieme, Aerie Pharmaceuticals (C), Thea pharma (C); M.B. Hoffmann, None; L. Choritz, None